FDA Approved: MOUNJARO — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved a supplemental application for MOUNJARO (tirzepatide) from Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MOUNJARO (tirzepatide)

Snippet

SUPPL AP for MOUNJARO (TIRZEPATIDE)